Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Qi Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0480-2110; OpenAlex author ID A5100650225. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. ATP-binding cassette subfamily A member 5 suppresses pancreatic ductal adenocarcinoma progression and chemoresistance by promoting β-catenin ubiquitin-dependen… Last author DOI 10.1016/j.drup.2026.101381↗
  2. NSUN6 deficiency drives immune suppression in pancreatic cancer via the KDM5A-CCL2-macrophage axis. Co-author DOI 10.1136/gutjnl-2025-336541↗
  3. Associations between triglyceride-glucose related indices and the risk of incident pancreatic cancer: a large-scale prospective cohort study in the UK Biobank. Last author DOI 10.1186/s12885-025-13718-8↗
  4. Identification and validation of stemness-based and ferroptosis-related molecular clusters in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2024.101877↗
  5. LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4. Co-author DOI 10.1186/s13062-024-00463-4↗
  6. A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma. Co-author DOI 10.1016/j.heliyon.2023.e21642↗
  7. ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway. Co-author DOI 10.1186/s13046-022-02310-8↗
  8. Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. Co-author DOI 10.1155/2021/9949272↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zuyi Ma · 6 shared papers, 2021–2026 · strength 1.11
  2. Chuanzhao Zhang · 6 shared papers, 2021–2025 · strength 1.07
  3. Shanzhou Huang · 6 shared papers, 2021–2025 · strength 1.07
  4. Baohua Hou · 6 shared papers, 2021–2025 · strength 1.07
  5. Zhenchong Li · 5 shared papers, 2021–2026 · strength 0.86
  6. Zelong Wu · 3 shared papers, 2023–2025 · strength 0.60
  7. Hongkai Zhuang · 3 shared papers, 2021–2024 · strength 0.45
  8. Zixuan Zhou · 3 shared papers, 2021–2024 · strength 0.45
  9. Shanzhou Huang · 1 shared paper, 2026 · strength 0.24
  10. Ziming Chen · 1 shared paper, 2026 · strength 0.23
  11. Lingxing Zeng · 1 shared paper, 2026 · strength 0.23
  12. Xudong Huang · 1 shared paper, 2026 · strength 0.23
  13. Jiachun Su · 1 shared paper, 2026 · strength 0.23
  14. Jialiang Zhang · 1 shared paper, 2026 · strength 0.23
  15. Zilan Xu · 1 shared paper, 2026 · strength 0.23
  16. Chunling Xue · 1 shared paper, 2026 · strength 0.23
  17. Zhongyan Zhang · 1 shared paper, 2024 · strength 0.21
  18. Shiye Ruan · 1 shared paper, 2024 · strength 0.21
  19. Hailiang Wang · 1 shared paper, 2024 · strength 0.21
  20. Shujie Wang · 1 shared paper, 2023 · strength 0.17
  21. Yuanfeng Gong · 1 shared paper, 2021 · strength 0.11
  22. Yiping Zou · 1 shared paper, 2021 · strength 0.11
  23. Bowen Huang · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.